Watch Ticker

Sight Sciences, Inc. Common Stock

Go to Sight Sciences, Inc. Common Stock Website

$3.49

0.02 (0.58%)

Live

Previous Close

$3.49

Day Range

$3.38 - $3.54

Previous Day Range

$3.275 - $3.48

Market Cap

$179.4 million USD

Day Vol.

146539

Previous Day Vol.

106404

Currency

USD

Primary Exchange

Nasdaq

Sight Sciences Inc is an ophthalmic medical device company focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. Its Surgical Glaucoma segment's product portfolio featur...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Nathan Lighthizer Et Al. - Sight Sciences Announces the Results of a Cost-Utility Analysis Demonstrating Cost Savings and Greater Health Utility with the TearCare® System Compared to Cyclosporine 0.05% for Treating Meibomian Gland Disease-Associated Dry Eye Disease

A cost-utility analysis revealed that TearCare® System offers cost savings and better health utility compared to cyclosporine 0.05% for treating meibomian gland disease-associated dry eye disease, with $903 annual per-patient savings.

Related tickers: SGHT.

Read Full Article

Sight Sciences, Inc. - Sight Sciences Announces the Publication of the 24-Month Results of the SAHARA RCT Demonstrating the Durability of the TearCare® Procedure for the Treatment of Dry Eye Disease

Sight Sciences published 24-month results of the SAHARA clinical trial demonstrating the durability of the TearCare® System for treating dry eye disease, showing statistically significant improvements in patient symptoms and eye health metrics through two annual treatments.

Related tickers: SGHT.

Read Full Article

Trending Tickers

Please sign in to view